市場調查報告書

美國的醫療用大麻市場、預測:2022年

US Medical Marijuana Market, Forecast to 2022

出版商 Frost & Sullivan 商品編碼 670596
出版日期 內容資訊 英文 98 Pages
商品交期: 最快1-2個工作天內
價格
美國的醫療用大麻市場、預測:2022年 US Medical Marijuana Market, Forecast to 2022
出版日期: 2018年07月18日內容資訊: 英文 98 Pages
簡介

本報告提供美國的醫療用大麻市場相關分析,市場概要,競爭情形,市場成長的推動要素、阻礙因素,醫療用大麻市場整體及各市場區隔 (醫療大麻,CBD) 市場分析與預測等資訊。

第1章 摘要整理

第2章 市場概要

第3章 競爭劇本

  • FDA已核准的大麻為基礎的合成產品
  • 市場機會
  • 破壞性的市場參與企業
  • 調查結果的評估
  • 民營企業的股權契約

第4章 促進要素、抑制因素:醫療用大麻市場全體

  • 促進因素
  • 促進因素的說明
  • 阻礙因素
  • 阻礙因素的說明

第5章 預測、趨勢:醫療用大麻市場全體

  • 預測的前提條件、定義
  • 調查手法、預測的前提條件
  • 醫療用大麻市場:概要
  • 醫療大麻的收益:各州
  • 醫療用大麻的預測:各市場區隔
  • 收益預測的討論

第6章 醫療大麻市場區隔

  • 醫療大麻的主要調查結果
  • 醫療用大麻產業的生態系統的轉換
  • 醫療大麻:地區圖
  • 醫療大麻:各州的患者數
  • 市場工程標準
  • 醫療大麻的收益預測
  • 收益預測的討論
  • 收益預測:各細分區隔
  • 收益預測:各細分區隔的討論

第7章 CBD (大麻二酚) 市場區隔

  • CBD的主要調查結果
  • 市場工程標準
  • CBD的收益預測
  • 收益預測的討論
  • 收益預測:各細分區隔
  • 收益預測:各細分區隔的討論

第8章 總論

第9章 附錄

第10章 FROST & SULLIVAN

目錄
Product Code: K27E-52

Medical Cannabis Revenue will Overtake Recreational in the Next 4 Years

The medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal level, marijuana is still considered an illegal Schedule 1 drug. Individual states, however, have laws in place for the legal use of medical marijuana, and in some states, for the use of recreational marijuana. Cannabidiol (CBD) products are also legally available in some US states as well as in many other countries. The market generates a lot of money, though much of that money is still considered a black market.

Many business segments are involved with the development of the medical marijuana market. Some businesses directly touch the plant product, such as growers, packers, transporters, and sellers. Other businesses operate in the medical marijuana industry but do not touch the plant product, including legal services, marketing and brand services, data and analytical services, insurance participants and hardware or software companies. The rules differ depending upon where a company stands related to the marijuana plant. This is a very different model than is in place for traditional pharmaceutical products.

The medical marijuana segment of the marijuana industry includes marijuana plant products, CBD products, and synthetically derived products targeting the cannabidiol receptors CB1 and CB2. There are several synthetic products currently on the markets in many countries other than the US. As a matter of fact, in Canada, not only is medical marijuana approved for use on the national level, its use is covered by Health Canada, the national government insurance plan.

In the US, medical marijuana use is increasing, as many more states have approved it for use in several diseases. In addition, hundreds of clinical trials are underway, testing products under the watchful eye of the FDA. It has been reported in states where medical marijuana is approved for use for the treatment of pain, there have reductions in the use of opioid drugs. This decrease in opioid use may prove to be a valuable mechanism to curb the current opioid epidemic in the US.

Legal uncertainty related to the use of medical marijuana has limited big pharma investments into this space; however in non-US locations, companies are more interested in pursuing this area of research and development. Billions of dollars are being generated through this market. It is a growing market drawing keen interest from physicians, investors and regulators. Physician education will be crucial, as these products gain approval, as cannabis was not a part of the medical curriculum of many currently practicing physicians.

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Key Findings (continued)
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions this Study will Answer
  • Cannabis Segment Overview
  • CBD Segment Overview
  • Marijuana Market-Definitions and Market Segments
  • Market Engineering Measurements
  • Market Engineering Measurements (continued)
  • Companies to Watch
  • 3 Big Predictions

2. MARKET OVERVIEW

  • Cannabis Primer
  • Cannabinoids
  • Endocannabinoid System
  • Hemp Derived CBD Market
  • Federal Laws Regarding Cannabis & CBD Regulation
  • Federal Laws Regarding Cannabis & CBD Regulation (continued)
  • Federal Laws Regarding Cannabis & CBD Regulation (continued)
  • Federal Laws Regarding Hemp Regulation
  • Federal Oversight in Medical Cannabis Industry
  • Medical Cannabis-Federal versus State Regulations*
  • State-Specific Approved Marijuana/CBD Use
  • State-Specific Approved Marijuana/CBD Use (continued)
  • Medical Marijuana Business Sector Landscape
  • Medical Cannabis
  • Medical Cannabis Impact on Opioid Use
  • Cannabidiol (CBD)
  • CBD Impact on Healthcare Treatments
  • Cannabinoid (CB1 & CB2) Drugs in Development
  • Cannabinoid Drugs in Development (continued)
  • Cannabinoid Drugs in Development (continued)
  • Cannabinoid Drugs in Development (continued)
  • Cannabinoid Drugs in Development (continued)
  • 2018 Marijuana Conferences

3. COMPETITIVE PLAYBOOK

  • FDA-Approved Cannabinoid-Based Synthetic Products
  • Market Opportunities
  • Disruptive Market Participants
  • Funding Assessment
  • Funding Assessment (continued)
  • Private Company Equity Deals
  • Private Company Equity Deals (continued)

4. DRIVERS AND RESTRAINTS-TOTAL MEDICAL MARIJUANA MARKET

  • Market Drivers
  • Drivers Explained
  • Drivers Explained (continued)
  • Market Restraints
  • Restraints Explained
  • Restraints Explained (continued)

5. FORECAST AND TRENDS-TOTAL MEDICAL MARIJUANA MARKET

  • Forecast Assumptions and Definitions
  • Methodology and Forecast Assumptions
  • Medical Marijuana Market-An Overview
  • Medical Cannabis Revenue by State
  • Medical Marijuana Forecast by Segment
  • Revenue Forecast Discussion

6. MEDICAL CANNABIS SEGMENT

  • Key Findings for Medical Cannabis
  • Transformation in the Medical Marijuana Industry Ecosystem, 2018
  • Medical Cannabis-Regional Picture
  • Medical Cannabis-Patients by State
  • Market Engineering Metrics
  • Medical Cannabis Revenue Forecast
  • Revenue Forecast Discussion
  • Revenue Forecast by Sub-segment
  • Revenue Forecast by Sub-segment Discussion

7. CBD SEGMENT

  • Key Findings for CBD
  • Market Engineering Metrics
  • CBD Revenue Forecast to 2022
  • Revenue Forecast Discussion
  • CBD Sub-segment Revenue Forecast
  • Revenue Forecast by Sub-segment Discussion

8. THE LAST WORD

  • The Last Word-3 Big Predictions
  • Legal Disclaimer

9. APPENDIX

  • Appendix-List of Marijuana Industry Keywords & Acronyms
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)

10. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy